| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |